Maria Herrera
Overview
Explore the profile of Maria Herrera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
1185
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sanchez A, Duran G, Cerdas M, Gutierrez J, Segura A, Herrera M, et al.
Toxicon X
. 2024 Dec;
24:100213.
PMID: 39640251
Recent research suggests that a polygeneric immunogen made from the venoms of the most medically important viperid and elapid snakes in sub-Saharan Africa could elicit a broader antibody response in...
2.
Segura A, Moscoso E, Umana D, Vargas M, Sanchez A, Hernandez A, et al.
Toxicon X
. 2024 Sep;
24:100206.
PMID: 39290878
Snakebite in the Middle East and North Africa (MENA) is a public health problem whose magnitude is not fully known. Several antivenoms are available in these regions, but these formulations...
3.
Sanchez A, Cerdas M, Gutierrez J, Vargas M, Segura A, Herrera M, et al.
Toxicon X
. 2024 Sep;
23:100202.
PMID: 39246647
The performance of dynamic body-feed filtration (DBF) in the removal of bulky solids produced during the manufacturing of snake antivenoms using the caprylic acid method was evaluated. For this purpose,...
4.
Sanchez A, Duran G, Segura A, Herrera M, Vargas M, Villalta M, et al.
PLoS Negl Trop Dis
. 2024 May;
18(5):e0012187.
PMID: 38809847
Background: Snakebite envenomation inflicts a high burden of mortality and morbidity in sub-Saharan Africa. Antivenoms are the mainstay in the therapy of envenomation, and there is an urgent need to...
5.
Machado F, Marta-Enguita J, Gomez S, Rodriguez J, Paramo-Fernandez J, Herrera M, et al.
Int J Mol Sci
. 2024 Apr;
25(8).
PMID: 38673963
Accurate etiologic diagnosis provides an appropriate secondary prevention and better prognosis in ischemic stroke (IS) patients; still, 45% of IS are cryptogenic, urging us to enhance diagnostic precision. We have...
6.
Gomez A, Sanchez A, Duran G, Villalta M, Segura A, Vargas M, et al.
Toxicon X
. 2024 Jan;
21:100183.
PMID: 38274651
Snakebite envenomation is a neglected tropical disease posing a high toll of mortality and morbidity in sub-Saharan Africa. Polyspecific antivenoms of broad effectiveness and specially designed for this region require...
7.
Marta-Enguita J, Navarro-Oviedo M, Machado F, Bermejo R, Aymerich N, Herrera M, et al.
J Thromb Haemost
. 2023 Dec;
22(4):1080-1093.
PMID: 38160727
Background: Active coagulation factor XIII (FXIII) catalyzing crosslinking of fibrin and other hemostatic factors plays a key role in clot stability and lysis. Objectives: To evaluate the effect of FXIII...
8.
Gomez A, Sanchez A, Duran G, Villalta M, Segura A, Vargas M, et al.
PLoS Negl Trop Dis
. 2023 Aug;
17(8):e0011545.
PMID: 37582064
Background: Envenomations by African snakes represent a high burden in the sub-Sahara region. The design and fabrication of polyspecific antivenoms with a broader effectiveness, specially tailored for its use in...
9.
Huertas R, Arguedas M, Estrada J, Moscoso E, Umana D, Solano G, et al.
Toxicon X
. 2023 May;
18:100158.
PMID: 37180815
During the production of snake antivenoms, the animals used as immunoglobulin source are subjected to processes that could deteriorate their physical condition. Therefore, these conditions must be carefully designed and...
10.
Arguedas M, Umana D, Moscoso E, Garcia A, Pereira C, Sanchez A, et al.
Vaccine X
. 2022 Nov;
12:100233.
PMID: 36337837
Adjuvant emulsions are widely used to enhance the antibody response in animals used as immunoglobulin source to produce snake antivenoms. We tested the performance of four commercial emulsion adjuvants (Montanide,...